Ryan N. Henderson

Array ( [id] => 5693670 [patent_doc_number] => 20060153817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Cartilage and bone repair and regeneration using postpartum-derived cells' [patent_app_type] => utility [patent_app_number] => 11/321863 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51590 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20060153817.pdf [firstpage_image] =>[orig_patent_app_number] => 11321863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5865056 [patent_doc_number] => 20060099186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins' [patent_app_type] => utility [patent_app_number] => 11/315277 [patent_app_country] => US [patent_app_date] => 2005-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9370 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099186.pdf [firstpage_image] =>[orig_patent_app_number] => 11315277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17235559 [patent_doc_number] => 11179422 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-23 [patent_title] => Method of differentiating umbilical cord tissue into a chondrogenic phenotype [patent_app_type] => utility [patent_app_number] => 11/315969 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 62533 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 231 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11315969 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 210310 [patent_doc_number] => 07625743 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-01 [patent_title] => 'Receptor for a Bacillus thuringiensis toxin' [patent_app_type] => utility [patent_app_number] => 11/311442 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 29 [patent_no_of_words] => 12434 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/625/07625743.pdf [firstpage_image] =>[orig_patent_app_number] => 11311442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7694013 [patent_doc_number] => 20080120731 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-22 [patent_title] => 'Transgenic Animal Models for Neurodevelopmental Disorders' [patent_app_type] => utility [patent_app_number] => 11/792380 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 16345 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20080120731.pdf [firstpage_image] =>[orig_patent_app_number] => 11792380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5847783 [patent_doc_number] => 20060123504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Methods of producing polyclonal antibodies' [patent_app_type] => utility [patent_app_number] => 11/296119 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 45320 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20060123504.pdf [firstpage_image] =>[orig_patent_app_number] => 11296119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5744487 [patent_doc_number] => 20060090213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Transgenic mice containing Kir5.1 inwardly rectifying potassium channel gene disruptions' [patent_app_type] => utility [patent_app_number] => 11/296809 [patent_app_country] => US [patent_app_date] => 2005-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20539 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20060090213.pdf [firstpage_image] =>[orig_patent_app_number] => 11296809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4893361 [patent_doc_number] => 20080102459 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'Method of Screening Antiobesity Agents' [patent_app_type] => utility [patent_app_number] => 11/792191 [patent_app_country] => US [patent_app_date] => 2005-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22553 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102459.pdf [firstpage_image] =>[orig_patent_app_number] => 11792191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5722735 [patent_doc_number] => 20060075512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Transgenic mice containing PAFR gene disruptions' [patent_app_type] => utility [patent_app_number] => 11/284710 [patent_app_country] => US [patent_app_date] => 2005-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19504 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20060075512.pdf [firstpage_image] =>[orig_patent_app_number] => 11284710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5722736 [patent_doc_number] => 20060075513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-06 [patent_title] => 'Avian transgenesis and exogenous proteins' [patent_app_type] => utility [patent_app_number] => 11/274674 [patent_app_country] => US [patent_app_date] => 2005-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14869 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20060075513.pdf [firstpage_image] =>[orig_patent_app_number] => 11274674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5103038 [patent_doc_number] => 20070186300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Transgenic mouse capable of over-expressing VE-PTP' [patent_app_type] => utility [patent_app_number] => 11/271624 [patent_app_country] => US [patent_app_date] => 2005-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10644 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20070186300.pdf [firstpage_image] =>[orig_patent_app_number] => 11271624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5867401 [patent_doc_number] => 20060101533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Transgenic mice containing TMEM3 beta-1,3-N-acetylglucosaminyltransferase gene disruptions' [patent_app_type] => utility [patent_app_number] => 11/269213 [patent_app_country] => US [patent_app_date] => 2005-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25508 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20060101533.pdf [firstpage_image] =>[orig_patent_app_number] => 11269213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5809623 [patent_doc_number] => 20060095979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Transgenic mice containing CLCN4 chloride ion channel gene disruptions' [patent_app_type] => utility [patent_app_number] => 11/261384 [patent_app_country] => US [patent_app_date] => 2005-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21800 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20060095979.pdf [firstpage_image] =>[orig_patent_app_number] => 11261384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9073894 [patent_doc_number] => 08551470 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Use of substance P for mobilization of Mesenchymal stem cells or proliferation of Mesenchymal stem cells and for wound healing or facilitating wound healing' [patent_app_type] => utility [patent_app_number] => 11/259550 [patent_app_country] => US [patent_app_date] => 2005-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 19 [patent_no_of_words] => 6356 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11259550 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5816774 [patent_doc_number] => 20060085865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Transgenic mice containing GPCR-like gene disruptions' [patent_app_type] => utility [patent_app_number] => 11/251226 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26515 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20060085865.pdf [firstpage_image] =>[orig_patent_app_number] => 11251226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479659 [patent_doc_number] => 20090202616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Composite, Method of Producing the Composite and Uses of the Same' [patent_app_type] => utility [patent_app_number] => 11/664164 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 9756 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202616.pdf [firstpage_image] =>[orig_patent_app_number] => 11664164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5880493 [patent_doc_number] => 20060029575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-09 [patent_title] => 'Compositions and methods for producing and using homogenous neuronal cell transplants' [patent_app_type] => utility [patent_app_number] => 11/242114 [patent_app_country] => US [patent_app_date] => 2005-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9489 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20060029575.pdf [firstpage_image] =>[orig_patent_app_number] => 11242114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4886362 [patent_doc_number] => 20080260694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Multipotential Expanded Mesenchymal Precursor Cell Progeny (Memp) and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/663563 [patent_app_country] => US [patent_app_date] => 2005-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 22024 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20080260694.pdf [firstpage_image] =>[orig_patent_app_number] => 11663563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4921626 [patent_doc_number] => 20080069941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'Animals for Conserving N-3 Highly Unsaturated Fatty Acids' [patent_app_type] => utility [patent_app_number] => 11/662413 [patent_app_country] => US [patent_app_date] => 2005-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7947 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20080069941.pdf [firstpage_image] =>[orig_patent_app_number] => 11662413 [rel_patent_id] =>[rel_patent_doc_number] =>)